Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

Lindholm, Lars H, Ibsen, Hans, Dahlöf, Björn, Devereux, Richard B, Beevers, Gareth, de Faire, Ulf, Fyhrquist, Frej, Julius, Stevo, Kjeldsen, Sverre E, Kristiansson, Krister, Lederballe-Pedersen, Ole, Nieminen, Markku S, Omvik, Per, Oparil, Suzanne, Wedel, Hans, Aurup, Peter, Edelman, Jonathan, Snapinn, Steven and Coats, A (2002) Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. The Lancet, 359 (9311). pp. 1004-1010. ISSN 1474-547X

Full text not available from this repository.
Item Type: Article
Faculty \ School:
Related URLs:
Depositing User: Rhiannon Harvey
Date Deposited: 01 Jul 2011 11:13
Last Modified: 21 Apr 2020 20:48
URI: https://ueaeprints.uea.ac.uk/id/eprint/33181
DOI: 10.1016/S0140-6736(02)08090-X

Actions (login required)

View Item View Item